Dual treatment with Val-083 and AZD1775 shows potent anti-tumor activity in diffuse midline glioma models.
Saved in:
| Title: | Dual treatment with Val-083 and AZD1775 shows potent anti-tumor activity in diffuse midline glioma models. |
|---|---|
| Authors: | Subramaniam B; Brain Tumor Institute, Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA., Roy D; Brain Tumor Institute, Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA., Woldegerima A; Brain Tumor Institute, Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA., Chong WC; Brain Tumor Institute, Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA., Przystal JM; Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Zhang J; Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Laternser S; Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Kritzer B; Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Rangnath S; University of Michigan, Ann Arbor, MI, USA., Knowles T; Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Yadavilli S; Brain Tumor Institute, Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA., Packer R; Brain Tumor Institute, Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA., Mueller S; Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.; Department of Neurology, Neurosurgery and Pediatrics, University of California San Francisco, San Francisco, CA, USA., Nazarian J; Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland. javad.nazarian@kispi.uzh.ch. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2025 Jul 01; Vol. 9 (1), pp. 209. Date of Electronic Publication: 2025 Jul 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
